Læknaneminn - 01.04.1994, Qupperneq 134

12. Carter BJ. Adeno-associated virus vectors. Current
Opinion in Biotechnology 1992; 3: 533-9.
13. Wu GY, Wu CH. Receptor-mediated in vitro gene
transformation by a soluble DNA carrier system. J
Biol Chem 1987; 262: 4429-32.
14. Curiel DT, Wagner E, Cotten M et al. High-efficiency
gene transfer mediated by adenovirus coupled to
DNA-polylysine complexes. Hum Gene Ther 1992;
3: 147-154.
15. Zenke M, Steinlein P, Wagner E et al. Receptor-
mediated endocytosis of transferrin-polycation
conjugates: an efficient way to introduce DNA into
hematopoietic cells. Proc Natl Acad Sci USA 1990;
87: 3655-9.
16. Mannino RJ, Gould Fogerite S. Liposome-mediated
gene transfer. Biotechniques 1988; 6: 682-90.
17. Acsadi G, Dickson G, Love DR et al. Human
dystrophin expression in mdx mice after
intramuscular injection of DNA constructs. Nature
1991; 352: 815-8.
18. Chen CA, Okayama H. Calcium phosphate-mediated
gene transfer: A highly efficient transfection system
for stably transforming cells with plasmid DNA.
Biotechniques 1988; 6: 632-8.
19. McNally MA, Lebkowski JS, Okarma TB et al.
Optimizing electroporation parameters for a variety of
human hematopoietic cell lines. Biotechniques 1988;
6: 882-6.
20. Yao SN, Wilson JM, Nabel EG et al. Expression of
human factor IX in rat capillary endothelial cells:
toward somatic gene therapy for hemophilia B. Proc
Natl Acad Sci USA 1991; 88: 8101-5.
21. Karlsson S. Treatment of genetic defects in
hematopoietic cell function by gene transfer. Blood
1991; 78: 2481-92.
22. Mulligan RC. The basic science of gene therapy.
Science 1993; 260: 926-32.
23. Gupta S, Wilson JM, Chowdhury JR. Hepatocyte
transplantation: development of new systems for liver
repopulation and gene therapy. Semin Liver Dis.
1992; 12: 321-31.
24. Miller AD. Human gene therapy comes of age. Nature
1992; 357:455-60.
25. Wilson JM, Grossman M. Therapeutic strategies for
familial hypercholesterolemia based on somatic gene
transfer. Am J Cardiol 1993; 72: 59D-63D.
26. Friedmann T. Approaches to gene therapy of complex
multigenic diseases: cancer as a model and
implications for cardiovascular disease and diabetes.
Ann Med. 1992;24:411-7.
27. Cheng J, Yee JK, Yeargin J et al. Suppression of
acute lymphoblastic leukemia by the human wild-type
p53 gene. Cancer Res 1992; 52: 222-6.
28. Golumbeck PT, Lazenby AJ, Levitsky HI et al.
Treatment of established renal cancer by tumor cells
engineered to secret interleukin-4. Science 1991; 254:
713-6.
29. Culver KW, Ram Z, Wallbridge S et al. In vivo gene
transfer with retroviral vector-producer cells for
treatment of experimental brain tumors. Science
1992; 256: 1550-2.
30. Takamiya Y, Short P, Moolten FL et al. An
experimental model of retrovirus gene therapy for
malignant brain tumors. J Neurosurg 1993; 79: 104-
10. "
31. Chien KR. Molecular advances in cardiovascular
biology. Science. 1993; 260: 916-7.
32. Rubin EM, Krauss RM, Spangler EA et al. Inhibition
of early atherogenesis in transgenic mice by human
apolipoprotein AI. Nature 1991; 353: 265-7.
33. Simons M, Edelman ER, DeKeyser JL et al.
Antisense c-myb oligonucleotides inhibit intimal
arterial smooth muscle cell accumulation in vivo.
Nature 1992; 359: 67-70.
34. Jiao S, Gurevich V, Wolff JA. Long-term correction
of rat model of Parkinson’s disease by gene therapy.
Nature 1993;362:450-3.
35. Buchschacher GL, Jr. Molecular targets of gene
transfer therapy forHIV infection. JAMA 1993; 269:
2880-6.
36. Lisziewicz J, Sun D, Smythe J et al. Inhibition of
human immunodeficiency virus type 1 replication by
regulated expression of a polymeric Tat activation
response RNA decoy as a strategy for gene therapy in
AIDS. Proc Nat Acad Sci USA 1993; 90(17): 8000-
4.
37. Buonocore L, Rose JK. Blockade of human
immunodeficiency virus type 1 production in CD4+ T
cells by an intracellular CD4 expressed under control
of the viral long terminal repeat. Proc Nat Acad Sci
USA 1993; 90(7): 2695-9.
38. Harrison GS, Long CJ, Curiel TJ et al. Inhibition of
human immunodeficiency virus-1 production
resulting from transduction with a retrovirus
containing an HlV-regulated diphtheria toxin A chain
gene. Hum Gene Ther 1992; 3(5): 461-9.
39. McCarthy M. Gene therapy for HIV infection [news].
Lancet 1993; 342: 799.
40. Temin-HM. Safety considerations in somatic gene
therapy of human disease with retrovirus vectors.
Hum Gene Ther 1990; 1: 111-23.
124
LÆKNANEMINN 1 1994 47. árg.